Mouse genetics/genomics: An effective approach for drug target discovery and validation

被引:0
|
作者
West, DB
Iakougova, O
Olsson, C
Ross, D
Ohmen, J
Chatterjee, A
机构
[1] Parke Davis Lab Mol Genet, Alameda, CA 94502 USA
[2] Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
关键词
use; genetics; gene-mapping; target identification; transgenic; gene targeting;
D O I
10.1002/(SICI)1098-1128(200005)20:3<216::AID-MED6>3.3.CO;2-S
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The mouse has become the premier mammalian system for the identification of the genetic basis of both mono- and oligogenic disorders, as well as the understanding of complex diseases with gene-gene and gene-environment interactions. The similarity between human and mouse genetic disease is sometimes striking, while in ether cases the phenotypes are less similar. The ability to genetically map and then clone single gene disorders rapidly, and the emerging technologies that will allow the economical identification of the polygenes controlling quantitative traits further demonstrate the utility of the mouse as a model for gene discovery, Additionally, the ability to genetically manipulate the mouse through transgenesis and gene targeting allows for the testing of hypotheses regarding specific gene function and their role in disease. The utility of the mouse extends beyond being just a gene discovery tool to provide prevalidated targets. It can also be used for the development of animal models, and the testing of compounds in specifically constructed transgenic and knockout strains to further define the target and pathway of a therapeutic compound. (C) 2000 John Wiley & Sons, inc.
引用
收藏
页码:216 / 230
页数:15
相关论文
共 50 条
  • [1] Mouse genetics in drug target discovery and validation: no simple answers to complex problems
    Russ, A. P.
    Grosse, J.
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2007, 2 (10) : 1379 - 1387
  • [2] Genetics, genomics and drug discovery
    Harris, T
    [J]. MEDICINAL RESEARCH REVIEWS, 2000, 20 (03) : 203 - 211
  • [3] The genetics of asthma and the promise of genomics-guided drug target discovery
    El-Husseini, Zaid W.
    Gosens, Reinoud
    Dekker, Frank
    Koppelman, Gerard H.
    [J]. LANCET RESPIRATORY MEDICINE, 2020, 8 (10): : 1045 - 1056
  • [4] Genomics in target and drug discovery
    van Duin, M
    Woolson, H
    Mallinson, D
    Black, D
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 429 - 432
  • [5] APPLICATIONS OF GENETICS, GENOMICS AND BIOINFORMATICS IN DRUG DISCOVERY
    Bourgon, Richard
    Dewey, Frederick E.
    Kan, Zhengyan
    Li, Shuyu D.
    [J]. PACIFIC SYMPOSIUM ON BIOCOMPUTING 2018 (PSB), 2018, : 1 - 7
  • [6] Drug discovery and target validation
    Nuttall, ME
    [J]. CELLS TISSUES ORGANS, 2001, 169 (03) : 265 - 271
  • [7] Systems genetics for drug target discovery
    Penrod, Nadia M.
    Cowper-Sal-Iari, Richard
    Moore, Jason H.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2011, 32 (10) : 623 - 630
  • [8] Screening the receptorome: an efficient approach for drug discovery and target validation
    Strachan, Ryan T.
    Ferrara, Gina
    Roth, Bryan L.
    [J]. DRUG DISCOVERY TODAY, 2006, 11 (15-16) : 708 - 716
  • [9] Proteornics and genomics: Perspectives on drug and target discovery
    Ahn, Natalie G.
    Wang, Andrew H-J
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (01) : 1 - 3
  • [10] Application of genomics and proteomics in drug target discovery
    Zhang, H. M.
    Nan, Z. R.
    Hui, G. Q.
    Liu, X. H.
    Sun, Y.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2014, 13 (01) : 198 - 204